Moderna, Inc.
Long
Updated

MRNA target 300

362
Moderna has proven technological advantages of mRNA technology over conventional methods for treatment and vaccination.

with high volume of in pipeline products lead by moderna vaccine for covid19, the valuation of company is bound to grow with Healthcare being the theme for investment.
Note
70%target achieved.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.